Clinical Trials Sponsored by Ya'aqov Abrams

Total 599 results

Abramson Cancer Center at Penn Medicine

Recruiting

Functional Lung Imaging With DECT and 4DCT

Non Small Cell Lung Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer (ABBY)

Breast Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

BRCA1/2 Flu Vaccine

BRCA1 Mutation | BRCA2 Mutation

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

Mesotheliomas Pleural

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies

MDS | Leukemia, Acute

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer

Women With Suspected or Confirmed Recurrent Breast Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy | Borderline Resectable Pancreatic Cancer Treated With Chemoradiotherapy

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma (MPM-PDT)

Epitheliod Malignant Pleural Mesothelioma

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer

Pancreatic Cancer

United States
Abramson Cancer Center at Penn Medicine

Enrolling by invitation

Cardiotoxicity of Cancer Therapy (CCT)

Breast Cancer

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer Prevention (BHB-CRC)

Colorectal Cancer

United States
Abramson Cancer Center at Penn Medicine

Enrolling by invitation

Improving Utilization of Supplemental Breast MRI Screening for Women With Extremely Dense Breasts

Breast Cancer

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer

Breast Cancer Stage IIB

United States
Abramson Cancer Center at Penn Medicine

Completed

A Randomized Pilot/Pharmacodynamic/Genomic Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer

Adenocarcinoma of the Pancreas

United States
Abramson Cancer Center at Penn Medicine

Terminated

Lymphoma RadVax LYMPHOMA: A PHASE II TRIAL OF NIVOLUMAB + LOW DOSE RADIOTHERAPY FOR INCOMPLETE RESPONDERS

Hodgkin Lymphoma

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck

Oropharyngeal Cancer | Human Papilloma Virus | Squamous Cell Carcinoma

United States
Abramson Cancer Center at Penn Medicine

Enrolling by invitation

Behavioral Economic Approaches for Population-Based Colorectal Cancer Screening

Colorectal Cancer

United States
Abramson Cancer Center at Penn Medicine

Enrolling by invitation

Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases

Pancreatic Diseases

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Telehealth Weight Loss Program for Breast Cancer Survivors (TWL)

Body Weight | Overweight and Obesity | Cancer of Breast | Cancer Survivors

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate Cancer

Prostate Cancer

United States
Abramson Cancer Center at Penn Medicine

Completed

Low-Level Laser in Head and Neck Chronic Lymphedema

Fibrosis | Head and Neck Cancer | Lymphedema

United States
Abramson Cancer Center at Penn Medicine

Completed

Text-based Intervention to Minimize the Time Burden of Routine Cancer Care (TIME)

Cancer | Solid Tumor | Telemedicine | Patient Empowerment

United States
Abramson Cancer Center at Penn Medicine

Completed

Behavioral Nudges to Improve Palliative Care Utilization in Advanced Cancer

Cancer

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

The Breast Program - Translational Cancer Resource

Breast Cancer

United States
Abramson Cancer Center at Penn Medicine

Completed

Assessing the Impact of a Financial Navigation Program for Patients With Multiple Myeloma

Multiple Myeloma

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Mild Hypofractionation With Proton Therapy or Intensity Modulated Radiation Therapy (IMRT) for Intermediate-Risk Prostate Cancer

Prostate Adenocarcinoma

United States
Abramson Cancer Center at Penn Medicine

Completed

Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas

Follicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle-Cell Lymphoma | Lymphoma, Small Lymphocytic | Marginal Zone B-Cell Lymphoma | MALT Lymphoma | Lymphoma of Mucosa-Associated Lymphoid Tissue

United States
Charite University, Berlin, Germany
Brahms AG

Completed

Impact of Therapy Optimization on the Level of Biomarkers in Patients With Decompensated Heart Failure (MOLITOR)

Decompensated Heart Failure

Germany
Abramson Cancer Center at Penn Medicine

Recruiting

[18F]FES PET/.CT in Uterine Cancer

Uterine Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

'Penny', a SMS Text-based Chatbot Intervention for Medication Adherence and Side Effect Management Among Patients With GI Cancers

Gastrointestinal Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy (BreastVAX)

Breast Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance

Non-small Cell Lung Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab

Melanoma | Melanoma Stage III

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Randomized Pilot Trial of Antimicrobial Therapy and Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Cancer

Early Stage Non-Small Cell Lung Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Suspected Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

No Restrictions on Diagnosis

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Project PLUS Lung Cancer Screening Promotion

Lung Cancer

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI)

Gastrointestinal Cancer

United States
Abramson Cancer Center at Penn Medicine

Completed

Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers

Melanoma | Breast Cancer | Pancreatic Cancer | Metastatic | Non Small Cell Lung Cancer (NSCLC)

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects

Prostate Adenocarcinoma

United States
Abramson Cancer Center at Penn Medicine

Completed

Phase II Study of Pembrolizumab After Curative Intent Treatment for Oligometastatic Non-Small Cell Lung Cancer

Oligometastatic Non-small Cell Lung Cancer (NSCLC)

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

FDG PET/CT in Lung Cancer Staging

Non-Small Cell Lung Cancer (NSCLC)

United States
Abramson Cancer Center at Penn Medicine

Completed

Trial of Consolidation Pembrolizumab After Concurrent Chemotherapy and Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Healthy Human Control Blood Collection for Validation of Biomarker Assay

Healthy

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer

Esophageal Cancer

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Proton Radiation For Meningiomas and Hemangiopericytomas

Meningioma | Hemangiopericytoma

United States
Abramson Cancer Center at Penn Medicine

Completed

A Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast Cancer

Advanced Breast Cancer

United States
Abramson Cancer Center at Penn Medicine

Completed

To Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal Cancer

Colorectal Cancer

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab (CCTGuide Pilot)

Heart Failure | Breast Cancer | Cardiomyopathies | Risk Factor, Cardiovascular | Cardiotoxicity | Toxicity Due to Chemotherapy

United States
Abramson Cancer Center at Penn Medicine

Terminated

Maintenance Rucaparib in BRCA1, BRCA2 or PALB2 Mutated Pancreatic Cancer That Has Not Progressed on Platinum-based Therapy

Pancreatic Cancer

United States

Clinical Trials Sponsored by Ya'aqov Abrams

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations